How can nanotechnology help to combat COVID-19? Opportunities and urgent need

被引:0
作者
Estefânia V. R. Campos
Anderson E. S. Pereira
Jhones Luiz de Oliveira
Lucas Bragança Carvalho
Mariana Guilger-Casagrande
Renata de Lima
Leonardo Fernandes Fraceto
机构
[1] Federal University of ABC. Av. dos Estados,Human and Natural Sciences Center
[2] São Paulo State University–UNESP,undefined
[3] Institute of Science and Technology,undefined
[4] Universidade de Sorocaba,undefined
来源
Journal of Nanobiotechnology | / 18卷
关键词
Coronavirus; SARS-CoV-2; Nanotechnology; Nanoparticles; Nanosensors; Nano-vaccines;
D O I
暂无
中图分类号
学科分类号
摘要
Incidents of viral outbreaks have increased at an alarming rate over the past decades. The most recent human coronavirus known as COVID-19 (SARS-CoV-2) has already spread around the world and shown R0 values from 2.2 to 2.68. However, the ratio between mortality and number of infections seems to be lower in this case in comparison to other human coronaviruses (such as severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV)). These outbreaks have tested the limits of healthcare systems and have posed serious questions about management using conventional therapies and diagnostic tools. In this regard, the use of nanotechnology offers new opportunities for the development of novel strategies in terms of prevention, diagnosis and treatment of COVID-19 and other viral infections. In this review, we discuss the use of nanotechnology for COVID-19 virus management by the development of nano-based materials, such as disinfectants, personal protective equipment, diagnostic systems and nanocarrier systems, for treatments and vaccine development, as well as the challenges and drawbacks that need addressing.[graphic not available: see fulltext]
引用
收藏
相关论文
共 794 条
  • [1] Dhama K(2014)Coronavirus infection in equines: a review Asian J Anim Vet Adv 9 164-176
  • [2] Pawaiya RVS(2019)Coronavirus envelope protein: current knowledge Virol J 16 69-273
  • [3] Chakrabort S(2020)A pneumonia outbreak associated with a new coronavirus of probable bat origin Nature 579 270-1207
  • [4] Tiwari R(2020)Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia N Engl J Med 382 1199-513
  • [5] Saminathan M(2020)Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Lancet. 395 507-160
  • [6] Verma AK(2020)The reproductive number of COVID-19 is higher compared to SARS coronavirus J Travel Med 27 taaa021-192
  • [7] Schoeman D(2020)WHO declares COVID-19 a pandemic Acta Bio Medica Atenei Parmensis. 91 157-574
  • [8] Fielding BC(2019)Origin and evolution of pathogenic coronaviruses Nat Rev Microbiol 17 181-269
  • [9] Zhou P(2020)Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding Lancet. 395 565-1263
  • [10] Yang X-L(2020)A new coronavirus associated with human respiratory disease in China Nature 579 265-569